07 3387 0400 [email protected] Region: Oceania Shop Now Account

WasteLog

Codonics

Note: A special price has been applied for your organisation.

Reduces the Risk of Drug Diversion

WasteLog® is a new system that better manages the workflow that prevails when analyzing the returns of narcotic drugs within a drug diversion prevention program. WasteLog® provides a fast, robust and highly accurate result in under 3 seconds.

Discover Broken Medication Chains

A key driver of drug diversion is the handling of medical waste, specifically unused narcotic drugs. Controlled substances that remain unopened after a completed surgical procedure need to be returned to the pharmacy. Similarly, opened but unused substances must be discarded. A quick test with WasteLog® will instantly verify a solution’s identity and concentration, thereby ensuring that it has not been tampered with. Using WasteLog® in your return procedure or waste disposal stream will help prevent attempts to divert controlled substances to illicit and inappropriate use.

Key Features of WasteLog®

  • Fast, robust and highly accurate result in <3 seconds
  • Vital component of Diversion Prevention programs
  • Measurement graphics available for qualitative analysis
  • Allows customers to calibrate new drugs themselves
  • Validates controlled drugs not consumed in the OR
  • Non-destructive: sample available for follow-up testing
  • Helps prevent elusive diversion attempts with data analysis

Codonics is a global corporation, providing the healthcare industry with some of the most advanced patient safety and medical imaging products on the market today. Headquartered in Cleveland, Ohio, Codonics is represented in over 110 countries with nearly 50,000 product installations. A standard of care in the operating room and a worldwide leader in image documentation solutions in radiology, Codonics technology can be found throughout the world’s leading healthcare facilities.

More from Codonics
WasteLog
https://imagingsol.com.au/product/wastelog

Want to Know More?